Ad is loading...
BEAM
Price
$26.68
Change
+$1.36 (+5.37%)
Updated
Dec 6, 04:59 PM (EDT)
86 days until earnings call
LGND
Price
$124.83
Change
+$1.32 (+1.07%)
Updated
Dec 6 closing price
60 days until earnings call
Ad is loading...

BEAM vs LGND

Header iconBEAM vs LGND Comparison
Open Charts BEAM vs LGNDBanner chart's image
Beam Therapeutics
Price$26.68
Change+$1.36 (+5.37%)
Volume$11.22K
CapitalizationN/A
Ligand Pharmaceuticals
Price$124.83
Change+$1.32 (+1.07%)
Volume$121.26K
CapitalizationN/A
BEAM vs LGND Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. LGND commentary
Dec 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and LGND is a Buy.

COMPARISON
Comparison
Dec 08, 2024
Stock price -- (BEAM: $26.71 vs. LGND: $124.83)
Brand notoriety: BEAM and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 96% vs. LGND: 107%
Market capitalization -- BEAM: $2.1B vs. LGND: $2.33B
BEAM [@Biotechnology] is valued at $2.1B. LGND’s [@Biotechnology] market capitalization is $2.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileLGND’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • LGND’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and LGND are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while LGND’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • LGND’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LGND is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -2.41% price change this week, while LGND (@Biotechnology) price change was +2.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

LGND is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGND($2.33B) has a higher market cap than BEAM($2.1B). LGND YTD gains are higher at: 74.783 vs. BEAM (-1.874). LGND has higher annual earnings (EBITDA): 95.8M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. LGND (220M). LGND has less debt than BEAM: LGND (7.36M) vs BEAM (162M). BEAM has higher revenues than LGND: BEAM (350M) vs LGND (152M).
BEAMLGNDBEAM / LGND
Capitalization2.1B2.33B90%
EBITDA-160.83M95.8M-168%
Gain YTD-1.87474.783-3%
P/E RatioN/A49.60-
Revenue350M152M230%
Total Cash926M220M421%
Total Debt162M7.36M2,202%
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
49
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMLGND
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
74%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
73%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 18 days ago
86%
Bearish Trend 10 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSCFX33.330.11
+0.33%
Mairs & Power Small Cap
USPFX31.860.08
+0.25%
Union Street Partners Value Advisor
MALRX24.220.04
+0.17%
BlackRock Advantage Large Cap Core Instl
FSMDX36.920.05
+0.14%
Fidelity Mid Cap Index
DRRCX15.830.02
+0.13%
BNY Mellon Global Real Return - C

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+5.49%
CRSP - BEAM
74%
Closely correlated
+5.70%
NTLA - BEAM
66%
Closely correlated
+7.84%
DNLI - BEAM
65%
Loosely correlated
+6.73%
RXRX - BEAM
63%
Loosely correlated
+21.55%
PRME - BEAM
62%
Loosely correlated
+10.10%
More